Clear Labs
Clear Labs is dedicated to delivering clarity in diagnostics to protect all life through innovative genomics, data analytics, and actionable insights. They focus on clinical and food safety testing using next-generation sequencing (NGS) technology, providing solutions for pathogen detection, surveillance, and food safety analysis. Their mission is to advance genomic surveillance and diagnostics to ensure safer food and better public health outcomes.
Industries
Nr. of Employees
medium (51-250)
Clear Labs
1559 Industrial Road San Carlos, CA 94070
Patents
Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
US-12305231-B2
View DetailsSystems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
US-11248265-B1
View DetailsDetection of microorganisms in food samples and food processing facilities
US-10676794-B2
View Details
Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
US-12305231-B2
View DetailsSystems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
US-11248265-B1
View DetailsDetection of microorganisms in food samples and food processing facilities
US-10676794-B2
View DetailsProducts
Automated sequencing platform (sample-to-result instrument)
An integrated, walkaway NGS instrument that automates sample processing, library preparation and run initiation to enable rapid, reproducible sequencing for clinical and food-safety applications. Platform operation and stated performance parameters are provided when used with designated, approved consumables and reagent kits.
NGS-based food-safety testing workflows
Automated targeted and metagenomic sequencing workflows for pathogen detection, serotyping, persistence monitoring, environmental mapping and food authenticity testing.
Automated sequencing platform (sample-to-result instrument)
An integrated, walkaway NGS instrument that automates sample processing, library preparation and run initiation to enable rapid, reproducible sequencing for clinical and food-safety applications. Platform operation and stated performance parameters are provided when used with designated, approved consumables and reagent kits.
NGS-based food-safety testing workflows
Automated targeted and metagenomic sequencing workflows for pathogen detection, serotyping, persistence monitoring, environmental mapping and food authenticity testing.
Services
Site evaluation, installation, configuration, and delivery options including purchase and lease arrangements for automated NGS systems; includes operator training and documented qualification activities.
Warranty and multi-year service plans with preventive maintenance visits, remote troubleshooting, parts replacement, RMA handling and contractual terms for fees, renewals and termination.
Field application scientist–led operator training and validation services including installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) with documentation to support regulatory readiness.
Site evaluation, installation, configuration, and delivery options including purchase and lease arrangements for automated NGS systems; includes operator training and documented qualification activities.
Warranty and multi-year service plans with preventive maintenance visits, remote troubleshooting, parts replacement, RMA handling and contractual terms for fees, renewals and termination.
Field application scientist–led operator training and validation services including installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) with documentation to support regulatory readiness.
Expertise Areas
- Clinical genomics and infectious disease surveillance
- Food safety testing and pathogen subtyping
- NGS automation and laboratory robotics
- Bioinformatics and cloud-based genomic data management
Key Technologies
- Next-generation sequencing (NGS)
- Whole-genome sequencing (WGS)
- Targeted NGS (tNGS)
- Short-read sequencing
News & Updates
Clear Labs announced the launch of its enhanced Clear Dx™ System with additional capabilities and the Clear Dx™ Microbial ID tNGS assay workflow, enabling next-day identification from sterile site specimens.
The company raised $30 million to accelerate development and adoption of sequencing solutions, with participation from major investors including Morgan Stanley, Felicis, GV, and others.
Evaluation of a fully automated bacteria WGS assay for Mycobacterium tuberculosis and non-tuberculosis Mycobacterium clinical isolates.
Evaluation of an automated, targeted NGS assay to detect and serotype Salmonella from sample enrichments.
The platform was evaluated and approved for Salmonella detection, performing as well or better than standard methods.
The platform was evaluated and approved for Listeria detection, with high sensitivity and specificity.
Clear Labs announced the launch of its enhanced Clear Dx™ System with additional capabilities and the Clear Dx™ Microbial ID tNGS assay workflow, enabling next-day identification from sterile site specimens.
The company raised $30 million to accelerate development and adoption of sequencing solutions, with participation from major investors including Morgan Stanley, Felicis, GV, and others.
Evaluation of a fully automated bacteria WGS assay for Mycobacterium tuberculosis and non-tuberculosis Mycobacterium clinical isolates.
Evaluation of an automated, targeted NGS assay to detect and serotype Salmonella from sample enrichments.
The platform was evaluated and approved for Salmonella detection, performing as well or better than standard methods.
The platform was evaluated and approved for Listeria detection, with high sensitivity and specificity.